Global Liver Institute
News
GLOBAL LIVER INSTITUTE
COVID-19 Updates and Treatments for Liver Cancer and Other Immunocompromised Patients
As the world continues to gain a better understanding of COVID-19 and ever present and new variants, Global Liver Institute wants to ensure that we are here to continue to guide, educate, and support the liver cancer community and other immunocompromised patients…
Women’s Health is Liver Health: Global Liver Institute’s Statement Affirming the Fundamental Right of Women to Full Spectrum of Reproductive Health Services
(Washington, D.C., May 3, 2022) – Global Liver Institute (GLI), a premier patient-led liver health nonprofit operating globally, is deeply concerned by the draft opinion published by POLITICO indicating the Supreme Court of the United States may overturn Roe v. Wade. A decision of this magnitude…
GLI’s Liver Cancers Team applauds Norman E. “Ned” Sharpless, M.D., for his passionate leadership of the National Cancer Institute
(Washington, D.C., April 29, 2022) – As leaders in the liver cancer community, Global Liver Institute and their Liver Cancers team expresses our gratitude and recognizes Dr. Ned Sharpless and his tremendous work as the Director of the National Cancer Institute (NCI), part of the National Institute…
Not So Rare: The Paradox of Rare Diseases
Welcome to the very first edition of Pediatric & Rare Liver Diseases News! As we expand our offerings for and about this community, Global Liver Institute is also committed to keeping you informed about what is happening with pediatric and rare liver diseases.
This edition is the first monthly community-specific newsletter within our new structure. Check out upcoming events in the pediatric and rare liver disease field, a patient’s perspective, exciting news, and more below.
Patient Story Feature: A normal day in my life with PBC by Bob Tyler
If you’ve ever seen the movie Groundhog Day, that’s probably the best example I can give about my experience with PBC. I know each and every day what my day will be like. Waking up is tedious due to the joints just aching because of no movement during the night. Feeling totally “unrested” even with 6 to 7 hours of sleep. Slowly making my way down…
GLI’s Liver Action Network Supports Living Donor Day and Urges for Increased Awareness of Living Donation
Today, April 6, the members of the Liver Action Network (LAN) pledge our collective support for Living Donor Day to honor the donors, recipients, families and caregivers, and clinical teams that make the lifesaving gift of organ donation possible globally. In connection with this pledge, the U.S. members…
Global Liver Institute Launches Its Liver Health Is Public Health Initiative
(Washington, D.C., March 30, 2022) – Global Liver Institute (GLI), a patient-led liver health nonprofit operating globally, today announced the launch of its global Liver Health is Public Health (LHPH) initiative with a special feature in the 2022 Your Liver supplement in the Guardian. Liver conditions continue to be misunderstood, mischaracterized, and stigmatized, resulting in under-diagnosis, under-treatment, and unnecessarily…
The Latest at GLI – March 2022
New Season, New Format: Striving to meet the needs of the expanding liver health- interested community for timely information on must-know events and news specific to our Council communities in Liver Cancer, NASH, Pediatric and Rare Liver Diseases, Liver Health Policy, and the activities of Global Liver Institute in a format and frequency that respects your busy lives we have reconfigured our newsletter schedule.
Building Equity into the Equation: Stopping NAFLD & NASH in Black Americans
Nonalcoholic steatohepatitis (NASH) has a relatively short history as a recognized health condition. The terminology for NASH and its precursor nonalcoholic fatty liver disease (NAFLD) date back to only the 1980s1. As a young disease, the stakeholders from throughout the field have the opportunity to integrate a health equity perspective into research, diagnosis…
Global Liver Institute Launches Final Nonalcoholic Steatohepatitis (NASH) Externally-Led Patient Focused Drug Development Meeting Outcome Report
On November 4th 2021, Global Liver Institute led an Externally Led Patient-Focused Drug Development Meeting on NASH. This GLI led EL-PFDD meeting on NASH provided regulators, and drug developers the invaluable opportunity to hear from patients and caregivers directly about the challenges and burdens of this life-threatening…
Global Liver Institute Announces the Fifth Annual International NASH Day on June 9
Washington, DC – March 7, 2022 – Global Liver Institute (GLI) will convene the fifth International NASH Day (#NASHday) on June 9, 2022 with the theme Stop NASH Now. This year, GLI is pleased to support grassroots efforts from around the globe that will raise awareness and promote diagnosis and care options in ways as unique as each community. Held annually on the second Thursday in June, #NASHDay…
GLI’s Liver Action Network Supports World Obesity Day to Acknowledge Strong Connection Between NASH and Obesity
As members of Global Liver Institute’s Liver Action Network (LAN), the undersigned organizations are proud to take part in World Obesity Day, and take action to recognize the bidirectional relationship between many chronic liver diseases like nonalcoholic steatohepatitis (NASH), and obesity. Worldwide, NASH affects more than 148 million people and continues to rise each year.1 Increasing amounts…